ARYx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	2005
Period Ending	Aug '25 Aug 8, 2025	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	2005
Market Capitalization	0	89	79	137	-	-	Upgrade
Market Cap Growth	-84.42%	11.83%	-42.05%	-	-	-	Upgrade
Enterprise Value	-	88	59	228	-	-	Upgrade
Last Close Price	0.00	3.21	2.90	7.75	-	-	Upgrade
PS Ratio	-	-	4.02	32.90	-	-	Upgrade
PB Ratio	-	-30.40	2.89	3.87	-	-	Upgrade
P/TBV Ratio	-	-	2.89	3.87	-	-	Upgrade
EV/Sales Ratio	-	-	3.00	54.79	-	-	Upgrade
Debt / Equity Ratio	-1.50	-3.47	0.50	0.20	0.58	0.78	Upgrade
Asset Turnover	-	-	0.33	0.07	0.11	-	Upgrade
Quick Ratio	0.38	0.89	4.05	4.69	4.36	3.40	Upgrade
Current Ratio	0.47	1.01	4.16	4.82	4.46	3.58	Upgrade
Return on Equity (ROE)	-	-270.76%	-99.48%	-105.40%	-175.00%	-	Upgrade
Return on Assets (ROA)	-74.86%	-61.44%	-31.48%	-28.48%	-39.26%	-	Upgrade
Return on Capital (ROIC)	-100.50%	-81.02%	-45.64%	-52.06%	-67.66%	-	Upgrade
Earnings Yield	-55539393.94%	-37.41%	-39.38%	-20.14%	-	-	Upgrade
FCF Yield	-60972727.27%	-39.60%	-57.85%	-20.61%	-	-	Upgrade
Buyback Yield / Dilution	-17.87%	-44.69%	-466.77%	-228.68%	-11.87%	-6.06%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.